Upgrade to SI Premium - Free Trial

Rocket Pharmaceuticals (RCKT) PT Raised to $12 at Leerink Partners

April 28, 2026 9:20 AM
Leerink Partners analyst Mani Foroohar raised the price target on Rocket Pharmaceuticals (NASDAQ: RCKT) to $12.00 (from $11.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change